Your search terms:
Facebook antitrust
Search results sorted by date
Tech
Consumers Ask for Court to Order Meta to Produce FTC Antitrust Case Docs
On Monday, the consumer plaintiffs suing Meta Platforms for antitrust abuses relating to its collection and use of user data wrote a letter brief...
Tech
Dismissal Briefing Ends in Facebook User and Advertiser Antitrust Class Action
Facebook Inc. has had the last word in its bid to dismiss the case over illegal monopolization and exclusionary conduct. Wednesday’s reply brief comes...
Tech
Non-Party Snap Pushes Back on Meta’s Bid to Subpoena Records in FTC’s Antitrust Case
An opposition filing submitted late last week by non-party Snap Inc., operator of the social media app SnapChat, claims that Meta Platforms is making...
Tech
Meta, FTC, File Joint Statement Considering Disqualifying Agency Chair From Antitrust Lawsuit
On Monday, the Federal Trade Commision (FTC) and defendants, Meta Platforms, Inc., Mark Zuckerberg and Within Unlimited, Inc., filed a joint statement of recent...
Tech
LinkedIn Urges Dismissal of Antitrust Suit Filed by Premium Users
On Tuesday, LinkedIn Corporation moved to dismiss a complaint filed by three users that brings claims for monopolization and attempted monopolization of the professional...
Tech
State AGs Prevail with Preliminary Antitrust Ruling in Digital Advertising Case Against Google
An opinion from the Southern District of New York issued earlier this week sided in large part with the attorneys general from 16 states...
Tech
11th Cir. Revives Online Advertising Antitrust Complaint Against Google
In a per curiam opinion issued last Friday, the Eleventh Circuit Court of Appeals overturned a ruling in favor of Google in an antitrust...
Tech
FTC and Meta Spar Over Discoverability of Agency Memoranda in Antitrust Spat
On Tuesday, the Federal Trade Commission (FTC) opposed Meta Platforms Inc.’s bid to compel production of two internal memoranda from 2012 and 2014 regarding...
- Advertisement -
Latest news
Latham and Covington Advise on Novartis’s Acquisition of Regulus
Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800...
The Crook, the Tycoon, the Short Seller, and Trump
FOIAengine Tracks the High Cost of Getting Even, and the Rewards
Until six weeks ago, Jason Galanis was Inmate 80739-198...
Pharma Knock-Offs, a Secret Email Address, and a Smooth Spin of the Revolving Door
The Latest Requests Logged in FOIAengine
Questions about GLP-1 weight loss drugs, DOGE, cryptocurrencies, and the past conduct of Trump’s...
